- Recently Played
- My Playlists
- Favourites
Your Music
No activties found
Info
- 0 Tracks
- Male
- Social Links
- Bio
-
It's anabolic influence largely dictated through genomic and non-genomic signaling, satellite cell activation, interaction with other anabolic signaling pathways, upregulation or downregulation of the androgen receptor, and potential roles in co-activators and transcriptional activity. Glucocorticoid exposure (237), acute endurance exercise (234), and hyperglycemia lead to increased KLF15 expression. Transcription factor Kruppel-like factor 15 (KLF15) is a direct target of the glucocorticoid receptor in skeletal muscle (212).
A 2-week training camp resulted in 30% decrease of blood testosterone levels with a simultaneous increase in CK creatine-kinase activity in the wrestlers. Several weeks' preparatory training was reported to have increased testosterone level by 5% to 14% in canoeists, and runners, and tennis players. Exercise intensifies the synthesis of testosterone and increases its concentration in blood circulation, but the changes depend on the intensity and duration of exercise. Also, cortisol and IGF-1 are both involved in the inflammatory response and exist on opposite sides of the anabolic-catabolic balance at skeletal muscle tissue. Additionally, IGF-1 levels eventually dropped for the athletes, with an increase in creatine kinase a marker used to assess tissue damage, suggesting a combination of extensive training-induced muscle damage and exhaustive depletion of these endocrine systems.
Future trials are needed to clarify the effects of the oestrogens on muscle biology under different conditions e.g., phase of menstrual cycle, pre or post-menopause, and the response to nutrition (fasting/feeding) and exercise training (Hansen, 2018). For example, low estrogen in the early follicular stage, may negatively affect RE-induced increases in estrogen levels (Hansen et al., 2012), while, in the luteal phase where circulating progesterone is relatively high, may also counteract the sensitizing effects of estrogen on muscle impairing any benefit of acute RE-induced during these phases (Hansen, 2018). Conversely, impaired testosterone responsiveness to RE in older adults, likely attenuates the AR response, due to lack of testosterone mediated AR increases, and subsequently, limits muscle mass gains with RET.
Due to these contrasting mechanisms of action, a combination of RE and RE-induced testosterone secretion will likely potentiate post exercise AR responses for longer, thereby augmenting adaptive muscle growth. Despite the contrasting hormonal profiles and significantly different acute testosterone responses in these environments, muscle mass and strength gains were comparable, suggesting that the role of testosterone (and other hormones) in exercise induced muscle adaptation is minimal. It therefore may be that the combined effects of acute testosterone elevation post exercise and sustained AR upregulation in the muscle may represent an additional mechanism through which RE might regulate muscle growth. Further, early increased circulating testosterone levels during RE are also LH-independent and it seems they may be directly stimulated via increases in lactate levels induced by an increase in the production of cAMP in testicular tissues (Lin et al., 2001). High affinity binding of LH at the Leydig cells of the testes activates a cyclic adenosine mono phosphate (cAMP) mechanism, resulting in increased testosterone synthesis (Dufau and Catt, 1979; Fry and Kraemer, 1997).
These results indicated GH has local effects that may be independent of increased levels of the circulating IGF-I (Ohlsson et al., 2009). The local production of IGF-1 is controlled primarily by GH and other hormones (e.g., parathyroid and thyroid hormones) (Bikle et al., 2015); suggesting GH's effect on growth may be mediated in part via increased local IGF-1 production and/or action. Bikle et al. also showed muscle atrophy was more pronounced after ablation of muscle IGF-1 production than when hepatic IGF-1 production was suppressed (Bikle et al., 2015); exhibiting circulating levels of IGF-1 (i.e., endocrine factor) do not effect overall growth responses (Ohlsson et al., 2000; Velloso, 2008). However, the main muscle anabolic effects of GH are believed to be indirect—via inducing the hepatic generation of IGF-1 triggering the IGF-1-Akt-mTOR pathway; in turn resulting in MPS augmentation and as a consequence muscle maintenance and growth (Sandri et al., 2013; Schiaffino et al., 2013).
Examples of other causes of shortness often treated with GH are Turner syndrome, Growth failure secondary to chronic kidney disease in children, Prader–Willi syndrome, intrauterine growth restriction, and severe idiopathic short stature. While GH replacement therapy has been proposed to treat depression as a result of GH deficiency, the long-term effects of such therapy are unknown. Major manifestations of GH deficiency in children are growth failure, the development of a short stature, and delayed sexual maturity. It is extremely rare for such a tumor to occur in childhood, but, when it does, the excessive GH can cause excessive growth, traditionally referred to as pituitary gigantism.citation needed Eventually, the adenoma may become large enough to cause headaches, impair vision by pressure on the optic nerves, or cause deficiency of other pituitary hormones by displacement.citation needed The most common disease of GH excess is a pituitary tumor composed of somatotroph cells of the anterior pituitary.
However, a study using a validated liquid chromatography-tandem mass spectrometry (LC–MS/MS) method for measuring T reported T levels were 1.8 times higher in pre-menopausal women with an average age of 35 years compared to post menopausal women with an average age of 59 years (Rothman et al., 2011). Additionally, endogenous testosterone release pulses are lower in frequency and amplitude at night in middle-aged men compared to young men (Luboshitzky et al., 2003). With advancing age in men, free and total testosterone begin to decrease between the third to fifth decade of life, and this decline continues progressively thereafter (Harman et al., 2001). Taken together, the data suggest the decline of circulating factors with aging may be a critical mechanism driving age-related alterations in the motor system. In addition to possible influences on muscle tissue, recent evidence has emerged indicating that circulating factors also have a profound influence on the nervous system, as Villeda et al. observed improved cognitive function in old mice injected with serum from young mice, while Ruckh et al. observed remyelination is enhanced in older mice via parabiosis with young mice (Ruckh et al., 2012, Villeda et al., 2014). The evidence for circulating factors has also been replicated as blood from young mice injected into old mice improves motor performance (Sinha et al., 2014). Thus, it is clear that with advancing age there is a plethora of form and function changes in the motoric system, and it is likely that these changes are linked to impairments in physical performance.
The concentration of ARs in skeletal muscle depends on the muscle fiber type, sex, training status, and androgen concentrations. AR protein content is a critical variable in RT-induced androgen-mediated skeletal muscle protein accretion in healthy men (31). The androgen/AR complex serves as a transcription factor leading to increased protein synthesis. Upon androgen binding to the ligand binding domain (LBD), dissociation from the heat-shock proteins occurs, hyperphosphorylation, dimerization, and conformational changes occur converting the AR to a transcription factor that interacts with androgen response elements or AREs of DNA (58). Phosphorylation may occur during ligand binding and through other signaling pathways indicating that the AR is cross-regulated by other ligand-receptor interactions (54). The signaling effects of androgens are mediated through the AR which belongs to a family of steroid receptors.
Although not heavily examined in humans, we review the few studies in the human literature that have examined the role of anabolic hormones on the motoric system. While these studies do not directly indicate that changes in anabolic hormones contribute to reduced human performance in the elderly (e.g., muscle weakness and physical limitations), they do suggest that additional research is warranted along these lines. → MOTS‑c falls under WADA’s Prohibited List, category S2→ Classified alongside "peptide hormones, growth factors, and related substances"→ Banned in- and out-of-competition→ Positive tests may result in disqualification or suspension → First thing in the morning on an empty stomach→ 30–60 minutes before fasted cardio or training→ On non-training days to maintain metabolic signaling MOTS‑c has been shown to increase aerobic performance by enhancing mitochondrial capacity and sparing glycogen during prolonged exercise. - https://mkhonto.net/@annmccaffrey4?page=about
Artists to Follow
Weekly Top Tracks
